The top workforce challenges cited in this year’s report were:
[COLOR=“blue”]• Biopharma cGMP (69.4%)
• Process validation (61.8%)
• Downstream processing (60.5%)
• FDA regulatory compliance (60.3%)[/color]
In the trenches, the 468 life sciences professionals who took part in BioPlan’s Sixth Annual Report on Biopharmaceutical Manufacturing cited biopharmaceutical production as a key area for future employment, and biopharmaceutical cGMP training as a skill set of “high” or “very high” need.